Clinical Laboratory

The 10th Conference on Candida and Candidiasis will provide a forum for the Candida research community to present the most recent developments, covering a broad spectrum, from clinical issues to molecular mechanisms, from growth of the fungus to response of the host.

The scientific program will feature nearly 300 individual colloquia, symposia, roundtable discussions, award lectures, & poster sessions. The 27 Division Chairs & the General Meeting Program Committee have devoted their energies to creating a well-rounded program.

The Largest Clinical Lab Exposition in the World. See new science and new technology in all areas of clinical diagnostics, automation, information systems, point-of-care, OEM, and biotech.

The 2010 ASCLS Annual Meeting is designed for you and your professional needs. The meeting offers educational topics that promote advanced learning in the science and practice of clinical laboratory science as well as opportunities to network, build social connections, etc.

Association of Kenya Medical Laboratory Scientific Officers (AKMLSO) which is the National Umbrella body representing all Medical Laboratory Scientists in Kenya in conjunction with International Federation of Biomedical Laboratory Science (IFBLS).

More than 10,000 physicians, researchers and other healthcare professionals from around the globe will gather at the 50th ICAAC to foster worldwide solutions to the problem of infectious disease.

Review and update in the areas of clinical immunology, microbiology, and infectious diseases is intended to improve knowledge about the pathogenesis and clinical manifestations of infectious diseases, immunological mechanisms of disease and disease prevention, etc.

ASM Conferences provide a forum for discussion and dissemination of specialized scientific information in an environment designed to encourage interaction amongst participants.

This meeting will cover numerous topics including morphogenesis, pathogenesis, molecular cell biology, host response, genomics, proteomics, and fungal evolution. Of special note is the “Sequence workshop/community tool-building session”.

This meeting will bring together researchers interested in all aspects of specialized recombination, from the biological to the structural and mechanistic. Research probing transposition in diverse organisms – including eubacteria, archaea, protists, plants, etc.

The conference will present the latest information on what clinical laboratories can, and SHOULD, be using to best diagnose infectious diseases, assist infection control, and serve patients.

The role of beneficial microbes in host development and physiology. Genetics of beneficial host-microbe associations. Ecology and evolution of microbial communities. The role of microbiota in normal immune function.

Genomics and Molecular Biology Pathogenicity Antibiotic Therapy and Resistance Bacteriocins Plasmids and Horizontal Transfer Epidemiology and Food Connections

Where else can you find tomorrow’s technology today? For more than 40 years, the Oak Ridge Conference has been the premier venue for emerging technologies that shape the future of testing in clinical diagnostic labs.

AABB’s Cellular Therapy and Transfusion Medicine Expo (CTTXPO) is our commitment to deliver Science, Education and Innovation in the exhibit hall to annual meeting attendees.

UK NEQAS for Cardiac Markers identified a requirement to initiate a dedicated meeting to educate and involve clinical scientists, biomedical scientists and clinicians in the continuously evolving area of cardiac markers and their role in diagnosis and treatment.

The Symposium on Bleeding and Thrombosis, hosted by Nichols Institute, is an entirely case-oriented seminar designed for healthcare professionals involved in the diagnosis and management of hemostasis and thrombotic disorders. Presented by leading experts, topics will include the use of pharmacogenetics to optimize anticoagulant therapy, platelet disorders, aspirin resistance, von Willebrand Disease, Lupus Anticoagulants, women's health issues, and pediatric hemostasis.

Together with the FDA and other professional organizations, AABB is planning a workshop on cord blood licensure. This event will feature a two-day workshop and will provide an opportunity to understand the FDA requirements for cord blood licensure.

In its 15th year, the reputation of the Executive War College on Laboratory and Pathology Management increases annually. It is a unique two-day program with a single objective: to help lab administrators and pathologists learn practical methods for improving the organizational performance and financial success of their laboratories.

The meeting will be hosted by the University of Texas Health Science Center–San Antonio. Drs. Robert L. Reddick and Robert L. Hunter, Jr., Co-Chairs of the Program Committee, cordially invite you to attend.

This exciting conference addresses all of the most innovative and advanced areas of laboratory technology and process improvement. You will understand how best to select new technologies so that you can work safer, smarter and more effectively.

This 3-day course will focus on current practices of molecular pathology, with an emphasis on case-based examples, technologies, and clinical applications.

Molecular subsets and HER2 testing guidelines in breast carcinoma. Prophylactic thyroid surgery decision-making based on Ret mutation screening in MEN II. EGFR, KRAS, and BRAF mutation screening in non-small cell lung carcinomas and colorectal carcinomas.

This 2.5 day meeting includes posters and presentations by clinicians and scientists who are on the emerging edge of changes in the point-of-care field.

This course offers a broad array of lecture topics beginning with a review of basic genomics and progressing to clinical applications. It is designed for individuals with an interest in understanding the ways in which genes not only affect mental illness, but impact disease course and prognosis. Pharmacogenomic principles that guide the treatment of psychiatric illness will be specifically highlighted.

The main goal of our symposium is to bring together basic science and clinical experts in the field of angiogenesis to facilitate the exchange of ideas and science involving basic biology and pathways of angiogenesis and new anti-angiogenic agents that can be used for specific targeting of tumor blood vessels and stroma. Moreover, the clinician scientists will present the results of ongoing clinical trials on anti-angiogenic therapy. This symposium will be a strong link in the establishment of a Mayo Clinic Angiogenesis Program. Furthermore, novel genetic as well as imaging methods to assess tumor vasculature for monitoring the effectiveness of angiogenic response in the pre-clinical and clinical trials will be discussed in this symposium. Overall, the symposium will assist in establishing strong collaborations among leading national, international, and Mayo Clinic experts in the field.